Contract Manufacturing

Novartis looks to work more strategically as CDMO

16-May-2022 By Jane Byrne

Novartis has recently set up a new contract development and manufacturing unit called Global Biotech Co-operations (GBTC).

Charles River, Valo join on AI-enabled drug discovery offering

10-May-2022 By Nick Taylor

The CRO has paired with the drug discovery technology firm on Logica, an artificial intelligence tool designed to accelerate development of new treatments.

FDA outlines benefit-risk approach to drug or biologic product quality assessment

10-May-2022 By Jane Byrne

The US FDA released new draft guidance yesterday discussing, among other challenges, how unresolved product quality issues might be addressed in the context of regulatory decision-making.

People on the Move: May 2022

05-May-2022 By Jenni Spinner

This month’s news on partnerships, appointments, expansions, and investment includes Javara, ACG, Phastar, Elligo Health Research, and other notable companies.

Survey: industry leaders looking to shore up pharma supply chain

05-May-2022 By Jenni Spinner

According to the 2022 EY CEO survey, life science executives are seeking to build resilience into their supply chains and dive into M&A opportunities.

CPHI North America

Future drugs will need novel excipients: IPEC

04-May-2022 By Jenni Spinner

An expert from the organization discusses ahead of his CPhI North America presentation how tomorrow’s drugs can’t all be formulated with yesterday’s excipients.

CPhI North America 2022

Continuous manufacturing adoption continues to rise: Pharmatech

04-May-2022 By Jenni Spinner

An expert from Pharmatech Associates offers a glimpse into the evolution of CM and previews a lively discussion during the upcoming CPhI North America event.

CPHI NORTH AMERICA 2022

US pharma hubs: The rising stars to watch

04-May-2022 By Rachel Arthur

CPhI North America 2022 host city Philadelphia is set to become one of the world’s biggest cell and gene therapy manufacturing hubs. But it’s just one of many centers of innovation that are helping drive the US pharma and biopharma industry.

Proposed bill aims to encourage US pharmaceutical manufacturing

03-May-2022 By Jenni Spinner

Introduced by two Republican Congressmen, the American Made Medicine Act is intended to boost domestic drug manufacturing and create jobs in the sector.

Yourway adds 100k square feet of temp-controlled storage capacity

28-Apr-2022 By Jenni Spinner

The addition of the facility in Pennsylvania will help meet the increasing demand for temperature-controlled clinical packaging, storage, and distribution.

Catalent to invest $350m to expand US drug substance and product manufacturing site

22-Apr-2022 By Jane Byrne

Catalent has announced a multi-year $350m investment at its facility in Bloomington, Indiana, to expand biologics drug substance and drug product manufacturing capabilities.

Lonza expands API development capacity at Nansha, China plant

21-Apr-2022 By Jenni Spinner

The pharma manufacturing specialist is increasing capacity at its development and manufacturing labs to meet growing global demand for highly potent APIs.

Advanced analytic tools can improve safety reporting: IQVIA

20-Apr-2022 By Jenni Spinner

An expert from the health tech company explains how AI, natural language processing, and other tools can improve pharmaceutical product safety reporting.

Inke to triple capacity for inhalation API manufacturing

20-Apr-2022 By Jenni Spinner

The maker of active pharmaceutical ingredients for inhaled treatments is investing €9m ($9.8m USD) to expand its manufacturing plant in Barcelona, Spain.

Clinical trial evolution, innovation center of Oracle Health Sciences event

20-Apr-2022 By Jenni Spinner

The two-day Oracle Health Sciences Connect will gather an array of research experts to discuss how to make the most of emerging technologies and practices.

Cryoport buys French biostorage and logistics specialist

19-Apr-2022 By Jane Byrne

Cryoport Inc has acquired Cell&Co BioServices, continuing its EMEA expansion efforts.

MyMeds&Me acquisition paves path for pharmacovigilance expansion

14-Apr-2022 By Jenni Spinner

The company’s recent purchase by Drug Safety and Pharmacovigilance Services Solutions reportedly will fuel expansion of its Reportum PV platform technology.

People on the Move: April 2022

11-Apr-2022 By Jenni Spinner

This month’s news includes hiring, promotions, expansions, and acquisitions at H Clinical, Charles River, DHL Supply Chain, X-Chem, and other key companies.

PharmaZell, Novasep merger creates new CDMO, API manufacturer

07-Apr-2022 By Jenni Spinner

The union of the active pharmaceutical ingredient supplier and contract development and manufacturing organization will create a global services company.

Novartis announces new organizational structure

05-Apr-2022 By Rachel Arthur

Novartis has created a new organizational structure and operating model: which it says will make the company more agile and competitive.

Tech Innovations: March 2022

17-Mar-2022 By Jenni Spinner

The latest news on software, manufacturing solutions, partnerships, and more includes IQVIA, TFF Pharmaceuticals, Quotient Sciences and other key companies.

Supply chain transparency could restore patient trust in pharma: Zebra

07-Mar-2022 By Jenni Spinner

The business tech company’s Pharmaceutical Supply Chain Vision Study gauges pharma and patient perceptions, including key concerns and areas for improvement.

People on the Move: March 2022

03-Mar-2022 By Jenni Spinner

This month’s announcements include hiring, expansion, and acquisition news from companies like DFE Pharma, ClinOne, Novartis, LEGO, Benchling, and more.

DCAT week 2022

DCAT Week 2022 to explore ‘what’s next for the industry’

03-Mar-2022 By Jenni Spinner

Returning to an in-person format March 21-24, the industry event is bringing a range of networking, educational, and social programming to New York City.

Bayer program streamlines clinical trial process, site relationships

17-Feb-2022 By Jenni Spinner

Created via a joint effort with EY, the pharmaceutical company launched ASPIREs, a program intended to improve its clinical trial processes in numerous areas.

Tech Innovations: February 2022

17-Feb-2022 By Jenni Spinner

This month’s list of announcements about technology, funding, and more includes Medable, Clarify Health, Thermo Fisher Scientific, and other key companies.

Merck restructures to strengthen CDMO business

14-Feb-2022 By Jane Byrne

Darmstadt, Germany headquartered, Merck KGaA, is restructuring its life sciences business.

SCOPE 2022

Clinical management platform enables vendor visibility: Strategikon Pharma

08-Feb-2022 By Jenni Spinner

Vision, part of the company’s Clinical Maestro platform of software-as-a-solution applications, enables study teams to manage clinical vendor oversight.

People on the Move: February 2022

03-Feb-2022 By Jenni Spinner

This month’s announcements include new hires, promotions, acquisitions, and other events from Saama, Javara, Firma, GlaxoSmithKline, and other companies.

Postponement strategies could alleviate pharma supply chain woes

24-Jan-2022 By Jenni Spinner

Experts from global professional services outfit Alvarez and Marsal outline challenges created or exacerbated by COVID-19 and insights into potential solutions.

Tech Innovations: January 2022

20-Jan-2022 By Jenni Spinner

This month’s list of new technology, partnerships, and other announcements includes items from ObvioHealth, Datavant, HumanFirst, and other industry players.

Pharma R&D investment report shows positive signs: Deloitte

14-Jan-2022 By Jenni Spinner

According to the company’s 12th Annual Pharmaceutical Innovation Report, pharmaceutical R&D return on investment has climbed to its highest peak since 2014.

FourKites, Accenture survey dives into supply chain concerns

10-Jan-2022 By Jenni Spinner

Checking in with pharma executives, the survey outlines leaders’ thoughts about current and future challenges, like costs, security, and inventory control.

Expect higher prices, limited availability of materials in 2022: CPhI Worldwide

06-Jan-2022 By Jenni Spinner

In a report outlining predictions for the coming year, the organization advises industry professionals to brace themselves for supply chain challenges.

People on the Move: January 2022

06-Jan-2022 By Jenni Spinner

This month’s news on mergers and acquisitions, hires, and other developments includes notable firms like Altasciences, Protocol First, WuXi STA, and more.

Clover Biopharmaceuticals begins construction of new R&D center in Shanghai

06-Jan-2022 By Rachel Arthur

Clover Biopharmaceuticals, a clinical-stage biotech developing novel vaccines and biologic therapeutic candidates, has started construction on a new R&D Center in Zhangjiang Biotech and Pharmaceutical Industrial Base in Shanghai.

Supply chain problems call for smart digital solutions: Vytal

04-Jan-2022 By Jenni Spinner

A leader from health tech solutions company Vytal examines supply chain challenges faced in the pharmaceutical field and shares some potential solutions.

Road ahead paved with innovation, opportunities: Syneos Health

04-Jan-2022 By Jenni Spinner

A forward-looking report from company experts includes a breakdown of the top trends to watch for in pharmaceutical development and in healthcare overall.

Lessons learned can help advance the future of DCTs: ObvioHealth

03-Jan-2022 By Jenni Spinner

A leader from the clinical trial technology company says that insights gained during the recent pandemic could be helpful in realizing future improvements.

Integrated development models key to supply chain success: Lonza

03-Jan-2022 By Jenni Spinner

An R&D leader from Lonza explains its proactive approach to staying on top of supply chain challenges, including a new dedicated manufacturing line in China.

Dogs, VR, and rock stars: OSP’s favorite items of 2021

22-Dec-2021 By Jenni Spinner

It has been a pleasure for the OSP team to connect with a long list of fascinating industry minds and share the stories; here are a few of our favorites.

Purchases, pandemic, and potential treatments: 2021’s greatest hits

22-Dec-2021 By Jenni Spinner

OSP’s list of the year’s most-read stories shows readers are interested in M&A activities, new drug candidates, COVID-19 developments, and other hot news.

Tech Innovations: December 2021

21-Dec-2021 By Jenni Spinner

This month’s collaborations, tech partnerships, new facilities, and other happenings includes news from Flywheel, Medable, Veeva, and other organizations.

Novo Nordisk weight-management treatment hits supply snag

20-Dec-2021 By Jenni Spinner

The pharmaceutical company has announced GMP-related challenges with a manufacturer contracted to fill syringes for Wegovy pens headed to the US market.

2021 year-end wrapup

Industry insights: obstacles, positives, and looking ahead

16-Dec-2021 By Jenni Spinner

Professionals from various corners of the life-sciences field share views on significant challenges of 2021, bright spots, and what to look for in 2022.

2021 year-end wrapup

Pandemic leads to challenges, opportunities in drug development: ACD/Labs

16-Dec-2021 By Jenni Spinner

A leader from the R&D tech provider discusses the obstacles faced by drug development professionals in recent months, and ways they rose to the occasion.

2021 year-end wrapup

Risk-based approach driving manufacturing improvements: Cognizant

16-Dec-2021 By Jenni Spinner

A leader from the information technology specialist explains how evolved thinking and digital transformation are leading to benefits across the industry.

Missing machine maintenance can come back to haunt you: I Holland

06-Dec-2021 By Jenni Spinner

A leader from the tabletting equipment specialist suggests keeping up with maintenance and repair can boost manufacturing efficiency and effectiveness.

People on the Move: December 2021

02-Dec-2021 By Jenni Spinner

This month’s announcements of awards, expansions, name changes, hires, and other news includes items from CPhI, Almac Group, ICON, and other organizations.

Johnson & Johnson to spin off consumer health business

12-Nov-2021 By Rachel Arthur

Johnson & Johnson has announced its intent to separate its Consumer Health business into a new publicly traded company: allowing J&J to put a sharpened focus on pharmaceuticals and medical devices.